Body composition changes in treatment-experienced HIV-infected patients initiating a tenofovir-containing antiretroviral regimen

被引：0
|
作者：
Tsekes, G
Mangafas, N
Tsogas, N
Psathas, C
Vlachadami, I
Batakis, N
Lazanas, MC
机构：
[1] Red Cross Hosp, Dept Internal Med 3, Athens, Greece
[2] Red Cross Hosp, Infect Dis Unit, Athens, Greece
[3] Red Cross Hosp, Dept Radiol, Athens, Greece
来源：
ANTIVIRAL THERAPY | 2004年 / 9卷 / 06期
关键词：
D O I：
暂无
中图分类号：
R51 [传染病];
学科分类号：
100401 ;
摘要：
046
引用
收藏
页码：L29 / L30
页数：2
相关论文
共 50 条
  • [41] Early Markers of Tubular Dysfunction in Antiretroviral-Experienced HIV-Infected Patients Treated with Tenofovir Versus Abacavir
    Maggi, Paolo
    Montinaro, Vincenzo
    Bellacosa, Chiara
    Pietanza, Stefania
    Volpe, Anna
    Graziano, Giusi
    Strippoli, Giovanni F. M.
    Angarano, Gioacchino
    AIDS PATIENT CARE AND STDS, 2012, 26 (01) : 5 - 11
  • [42] Long-distance interactive expert advice in highly treatment-experienced HIV-infected patients
    Llibre, Josep M.
    Domingo, Pere
    Del Pozo, Miguel A.
    Miralles, Celia
    Galindo, Maria J.
    Viciana, Isabel
    Moreno, Santiago
    Schapiro, Jonathan M.
    Clotet, Bonaventura
    JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY, 2008, 61 (01) : 206 - 209
  • [43] Tipranavir:: a new protease inhibitor for the treatment of antiretroviral-experienced HIV-infected patients
    de Mendoza, Carmen
    Morello, Judit
    Garcia-Gasco, Pilar
    Rodriguez-Novoa, Sonia
    Soriano, Vincent
    EXPERT OPINION ON PHARMACOTHERAPY, 2007, 8 (06) : 839 - 850
  • [44] Clinical management of treatment-experienced, HIV-infected patients with the fusion inhibitor enfuvirtide: consensus recommendations
    Clotet, B
    Raffi, F
    Cooper, D
    Delfraissy, JF
    Lazzarin, A
    Moyle, G
    Rockstroh, J
    Soriano, V
    Schapiro, J
    AIDS, 2004, 18 (08) : 1137 - 1146
  • [45] Risk of Liver Fibrosis in Hepatitis B Virus and HIV Coinfected Youths Receiving Tenofovir-Containing Antiretroviral Regimen
    Aurpibul, Linda
    Kanjanavanit, Suparat
    Leerapun, Apinya
    Puthanakit, Thanyawee
    JOURNAL OF THE INTERNATIONAL ASSOCIATION OF PROVIDERS OF AIDS CARE, 2019, 18
  • [46] Antiretroviral treatment in HIV-infected children who require a rifamycin-containing regimen for tuberculosis
    Rabie, Helena
    Decloedt, Eric H.
    Garcia-Prats, Anthony J.
    Cotton, Mark F.
    Frigati, Lisa
    Lallemant, Marc
    Hesseling, Anneke
    Schaaf, H. Simon
    EXPERT OPINION ON PHARMACOTHERAPY, 2017, 18 (06) : 589 - 598
  • [47] Cost-effectiveness of Raltegravir in Antiretroviral Treatment-Experienced HIV-1-Infected Patients in Switzerland
    Elbasha, E. E.
    Szucs, T.
    Chaudhary, M. A.
    Kumar, R. N.
    Roediger, A.
    Cook, J. R.
    Opravil, M.
    HIV CLINICAL TRIALS, 2009, 10 (04): : 233 - 253
  • [48] Improvement in lipid levels in antiretroviral-experienced HIV-infected patients who are failing therapy and are switched to an atazanavir-containing regimen
    Lichtenstein, K
    Clumeck, N
    Bellos, N
    Rodriguez, C
    Estrada, V
    Gialelis, K
    Sankoh, S
    Ledesma, E
    ANTIVIRAL THERAPY, 2003, 8 (04) : L79 - L80
  • [49] Novel Antiretroviral Combinations in Treatment-Experienced Patients with HIV InfectionRationale and Results
    Babafemi Taiwo
    Robert L. Murphy
    Christine Katlama
    Drugs, 2010, 70 : 1629 - 1642
  • [50] Antiretroviral regimens for treatment-experienced patients with HIV-1 infection
    Lagnese, Meena
    Daar, Eric S.
    EXPERT OPINION ON PHARMACOTHERAPY, 2008, 9 (05) : 687 - 700
12345